Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: A randomized controlled trial

Psychotherapy and Psychosomatics

Volumn 82, Issue 5, 2013, Pages 299-310

  Van Ravesteijn, Hiske ^a   Lucassen, Peter ^a   Bor, Hans ^a   Van Weel, Chris ^a   Speckens, Anne ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Medically unexplained symptoms; Mindfulness; Randomized controlled trial; Somatoform disorders

Indexed keywords

ADULT; AGED; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNEXPLAINED SYMPTOM; MENTAL DISEASE; MENTAL FUNCTION; MINDFULNESS; MINDFULNESS BASED COGNITIVE THERAPY; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKILL; SOCIAL INTERACTION;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; COGNITIVE THERAPY; FAMILY PRACTICE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MINDFULNESS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS; YOUNG ADULT;

EID: 84883144410     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000348588     Document Type: Article

References (47)

1. de Waal MW, Arnold IA, Eekhof JA, van Hemert AM: Somatoform disorders in general practice: Prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004; 184: 470-476.
2. Barsky AJ, Borus JF: Somatization and medicalization in the era of managed care. JAMA 1995; 274: 1931-1934.
3. Mayou R: Somatization: Psychother Psychosom 1993; 59: 69-83.
4. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3rd, Hahn SR, Brody D, Johnson JG: Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994; 272: 1749-1756.
5. Ring A, Dowrick CF, Humphris GM, Davies J, Salmon P: The somatising effect of clinical consultation: What patients and doctors say and do not say when patients present medically unexplained physical symptoms. Soc Sci Med 2005; 61: 1505-1515.
6. Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M, Herzog W, Konig HH: Economics of medically unexplained symptoms: A systematic review of the literature. Psychother Psychosom 2012; 81: 265-275.
7. Kroenke K: Efficacy of treatment for somatoform disorders: A review of randomized controlled trials. Psychosom Med 2007; 69: 881-888.
8. Deary V, Chalder T, Sharpe M: The cognitive behavioural model of medically unexplained symptoms: A theoretical and empirical review. Clin Psychol Rev 2007; 27: 781-797.
9. Speckens AE, van Hemert AM, Spinhoven P, Hawton KE, Bolk JH, Rooijmans HG: Cognitive behavioural therapy for medically unexplained physical symptoms: A randomised controlled trial. BMJ 1995; 311: 1328-1332.
10. Martens U, Enck P, Matheis A, Herzog W, Klosterhalfen S, Ruhl A, Zipfel S, Sammet I: Motivation for psychotherapy in patients with functional gastrointestinal disorders. Psychosomatics 2010; 51: 225-229.
11. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA: Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000; 68: 615-623.
12. Goldberg D, Gask L, Odowd T: The treatment of somatization-teaching techniques of reattribution. J Psychosom Res 1989; 33: 689-695.
13. Hofmann SG, Sawyer AT, Witt AA, Oh D: The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol 2010; 78: 169-183.
14. Britton WB, Haynes PL, Fridel KW, Bootzin RR: Mindfulness-based cognitive therapy improves polysomnographic and subjective sleep profiles in antidepressant users with sleep complaints. Psychother Psychosom 2012; 81: 296-304.
15. Sephton SE, Salmon P, Weissbecker I, Ulmer C, Floyd A, Hoover K, Studts JL: Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Arthritis Rheum 2007; 57: 77-85.
16. Morone NE, Greco CM, Weiner DK: Mindfulness meditation for the treatment of chronic low back pain in older adults: A randomized controlled pilot study. Pain 2008; 134: 310-319.
17. Lovas DA, Barsky AJ: Mindfulness-based cognitive therapy for hypochondriasis, or severe health anxiety: A pilot study. J Anxiety Disord 2010; 24: 931-935.
18. Surawy C, Roberts J, Silver A: The effect of mindfulness training on mood and measures of fatigue, activity, and quality of life in patients with chronic fatigue syndrome on a hospital waiting list: A series of exploratory studies. Behav Cogn Psychother 2005: 103-109.
19. Howe A, Parry G, Pickvance D, Hockley B: Defining frequent attendance: Evidence for routine age and sex correction in studies from primary care settings. Br J Gen Pract 2002; 52: 561-562.
20. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
21. First M, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSMIV Axis I Disorders, Clinician Version. Washington, American Psychiatric Press, 1996.
22. Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340:c332.
23. Kabat-Zinn J: Full Catastrophe Living, How to Cope with Stress, Pain and Illness Using Mindfulness Meditation. New York, Bantam Doubleday Dell Publishing, 1990.
24. Huijbers MJ, Spijker J, Donders AR, van Schaik DJ, van Oppen P, Ruhe HG, Blom MB, Nolen WA, Ormel J, van der Wilt GJ, Kuyken W, Spinhoven P, Speckens AE: Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: Trial design and protocol of the MOMENT study. BMC Psychiatry 2012; 12: 125.
25. Kuyken W, Byford S, Taylor RS, Watkins E, Holden E, White K, Barrett B, Byng R, Evans A, Mullan E, Teasdale JD: Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol 2008; 76: 966-978.
26. Group TE: EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
27. Ware JE Jr: SF-36 health survey update. Spine 2000; 25: 3130-3139.
28. Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282: 1737-1744.
29. Pilowsky I: Dimensions of hypochondriasis. Br J Psychiatry 1976; 113: 89-93.
30. Baer RA, Smith GT, Lykins E, Button D, Krietemeyer J, Sauer S, Walsh E, Duggan D, Williams JMG: Construct validity of the five facet mindfulness questionnaire in medita ting and nonmeditating samples. Assessment 2008; 15: 329-342.
31. Blankenstein N: Somatising Patients in General Practice: Reattribution, a Promising Approach. Amsterdam, Vrije Universiteit, 2001.
32. Pickard AS, Neary MP, Cella D: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007; 5: 70.
33. Borm GF, Fransen J, Lemmens WA: A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol 2007; 60: 1234-1238.
34. Campbell M, Grimshaw J, Steen N: Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group. J Health Serv Res Policy 2000; 5: 12-16.
35. Little RJ, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Neaton JD, Shih W, Siegel JP, Stern H: The design and conduct of clinical trials to limit missing data. Stat Med 2012; 31: 3433-3443
36. Donders AR, van der Heijden GJ, Stijnen T, Moons KG: Review: A gentle introduction to imputation of missing values. J Clin Epidemiol 2006; 59: 1087-1091.
37. Grossman P: Defining mindfulness by how poorly I think I pay attention during everyday awareness and other intractable problems for psychology's (re)invention of mindfulness: comment on Brown et al. (2011). Psychol Assess 2011; 23: 1034-1040;discussion 41-46.
38. Taylor GJ, Bagby RM, Parker JD: The alexithymia construct. A potential paradigm for psychosomatic medicine. Psychosomatics 1991; 32: 153-164.
39. De Gucht V, Heiser W: Alexithymia and somatisation: quantitative review of the literature. J Psychosom Res 2003; 54: 425-434.
40. Bohlmeijer E, Prenger R, Taal E, Cuijpers P: The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: A meta-analysis. J Psychosom Res 2010; 68: 539-544.
41. Fjorback LO, Arendt M, Ornbol E, Walach H, Rehfeld E, Schroder A, Fink P: Mindfulness therapy for somatization disorder and functional somatic syndromes-randomized trial with one-year follow-up. J Psychosom Res 2013; 74: 31-40.
42. Fjorback LO, Carstensen T, Arendt M, Ornbol E, Walach H, Rehfeld E, Fink P: Mindfulness therapy for somatization disorder and functional somatic syndromes: Analysis of economic consequences alongside a randomized trial. J Psychosom Res 2013; 74: 41-48.
43. Crane R, Kuyken W, Williams JM: Competence in teaching mindfulness-based courses: concepts, development and assessment. Mindfulness 2012; 3: 76-84.
44. van Aalderen JR, Donders AR, Giommi F, Spinhoven P, Barendregt HP, Speckens AE: The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: A randomized controlled trial. Psychol Med 2011; 1-13.
45. Freedland KE, Mohr DC, Davidson KW, Schwartz JE: Usual and unusual care: Existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med 2011; 73: 323-335.
46. Nakao M, Shinozaki Y, Ahern DK, Barsky AJ: Anxiety as a predictor of improvements in somatic symptoms and health anxiety associated with cognitive-behavioral intervention in hypochondriasis. Psychother Psychosom 2011; 80: 151-158.
47. Schaefert R, Kaufmann C, Wild B, Schellberg D, Boelter R, Faber R, Szecsenyi J, Sauer N, Guthrie E, Herzog W: Specific collaborative group intervention for patients with medically unexplained symptoms in general practice: A cluster randomized controlled trial. Psychother Psychosom 2012; 82: 106-119.